Stock Scorecard



Stock Summary for Fulgent Genetics Inc (FLGT) - $21.70 as of 3/28/2024 9:32:02 PM EST

Total Score

10 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for FLGT

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for FLGT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for FLGT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for FLGT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for FLGT

Privia Health ( PRVA ) Misses Q4 Earnings Estimates 2/27/2024 12:25:00 PM
Health Catalyst ( HCAT ) Q4 Earnings and Revenues Beat Estimates 2/22/2024 10:25:00 PM
Carrier Screening Market is Expected to Reach $5.4 Billion | MarketsandMarkets™ 2/15/2024 12:30:00 PM
Cooper Companies ( COO ) , Fulgent Unite to Boost Genetic Testing 2/12/2024 3:31:00 PM
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing - PR Newswire 2/9/2024 1:31:00 PM
Four Stocks With Big Rebound Potential: The Casualty List 1/15/2024 3:00:00 PM
Fulgent Genetics, Inc. ( FLGT ) Reports Q3 Loss, Tops Revenue Estimates 11/3/2023 12:45:00 PM
Strength Seen in Olink Holding AB ( publ ) Sponsored ADR ( OLK ) : Can Its 66.0% Jump Turn into More Strength? 10/18/2023 1:44:00 PM
Global Hereditary Testing Market Shows Strong 8.8% CAGR, Driving Demand for Hereditary Disorder Testing Kits 10/10/2023 6:15:00 PM
Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock ( NYSE:BMY ) , SenesTech, Inc. - Common Stock ( NASDAQ:SNES ) 10/4/2023 4:01:00 PM

Financial Details for FLGT

Company Overview

Ticker FLGT
Company Name Fulgent Genetics Inc
Country USA
Description Fulgent Genetics, Inc., provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. The company is headquartered in Temple City, California.
Sector Name LIFE SCIENCES
Industry Name SERVICES-MEDICAL LABORATORIES
Most Recent Quarter 12/31/2023
Next Earnings Date 5/3/2024

Stock Price History

Last Day Price 21.70
Last Day Price Updated 3/28/2024 9:32:02 PM EST
Last Day Volume 154,075
Average Daily Volume 269,071
52-Week High 44.09
52-Week Low 21.23
Last Price to 52 Week Low 2.21%

Valuation Measures

Trailing PE N/A
Industry PE 261.00
Sector PE 60.76
5-Year Average PE 3.74
Free Cash Flow Ratio 6.64
Industry Free Cash Flow Ratio 16.58
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 6.96
Total Cash Per Share 3.27
Book Value Per Share Most Recent Quarter 38.31
Price to Book Ratio 0.57
Industry Price to Book Ratio 2.70
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 2.23
Industry Price to Sales Ratio Twelve Trailing Months 1.49
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 29,784,800
Market Capitalization 646,330,160
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -98.60%
Annual Earnings Growth -217.03%
Reported EPS 12 Trailing Months -5.63
Reported EPS Past Year -0.41
Reported EPS Prior Year 5.70
Net Income Twelve Trailing Months -167,825,000
Net Income Past Year -167,825,000
Net Income Prior Year 143,403,000
Quarterly Revenue Growth YOY 4.10%
5-Year Revenue Growth 68.41%

Balance Sheet

Total Cash Most Recent Quarter 97,473,000
Total Cash Past Year 97,473,000
Total Cash Prior Year 79,506,000
Net Cash Position Most Recent Quarter 93,326,000
Net Cash Position Past Year 93,326,000
Long Term Debt Past Year 4,147,000
Long Term Debt Prior Year 5,639,000
Total Debt Most Recent Quarter 4,147,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 1,136,101,000
Total Stockholder Equity Prior Year 1,266,685,000
Total Stockholder Equity Most Recent Quarter 1,136,101,000

Options

Put/Call Ratio 0.08
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.80
MACD Signal -0.82
20-Day Bollinger Lower Band 20.84
20-Day Bollinger Middle Band 25.80
20-Day Bollinger Upper Band 30.75
Beta 1.45
RSI 42.30
50-Day SMA 30.25
200-Day SMA 51.94

System

Modified 3/28/2024 12:46:08 AM EST